000 01493 a2200469 4500
005 20250517180213.0
264 0 _c20190125
008 201901s 0 0 eng d
022 _a1747-0285
024 7 _a10.1111/cbdd.13116
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Min
245 0 0 _aLegumain correlates with neuroblastoma differentiation and can be used in prodrug design.
_h[electronic resource]
260 _bChemical biology & drug design
_c02 2018
300 _a534-544 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBlood Platelets
_xcytology
650 0 4 _aCell Differentiation
650 0 4 _aCell Line, Tumor
650 0 4 _aCysteine Endopeptidases
_xmetabolism
650 0 4 _aDoxorubicin
_xchemistry
650 0 4 _aDrug Design
650 0 4 _aHumans
650 0 4 _aKidney
_xdrug effects
650 0 4 _aLeukocytes
_xcytology
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Nude
650 0 4 _aNeuroblastoma
_xdrug therapy
650 0 4 _aPeptides
_xchemistry
650 0 4 _aProdrugs
_xchemical synthesis
650 0 4 _aTransplantation, Heterologous
700 1 _aJiang, Zhiteng
700 1 _aChen, Sheng
700 1 _aWu, Zhixiang
700 1 _aChen, Kai
700 1 _aWu, Yeming
773 0 _tChemical biology & drug design
_gvol. 91
_gno. 2
_gp. 534-544
856 4 0 _uhttps://doi.org/10.1111/cbdd.13116
_zAvailable from publisher's website
999 _c27647415
_d27647415